SpringWorks Therapeutics Inc Forecast, price target & analysts
SpringWorks Therapeutics Inc Target price 2025 - Analyst rating & recommendation
SpringWorks Therapeutics Inc Classifications & Recommendation:
SpringWorks Therapeutics Inc Price Target
| Target Price | $47.94 |
| Price | $46.98 |
| Potential |
2.04%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target SpringWorks Therapeutics Inc 2026 .
The average SpringWorks Therapeutics Inc target price is $47.94.
This is
2.04%
register free of charge
$88.20
87.74%
register free of charge
$47.47
1.04%
register free of charge
|
|
| A rating was issued by 11 analysts: 0 Analysts recommend SpringWorks Therapeutics Inc to buy, 8 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the SpringWorks Therapeutics Inc stock has an average upside potential 2026 of
2.04%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 191.59 | 334.05 |
| 3,415.41% | 74.36% | |
| EBITDA Margin | -143.36% | -54.87% |
| 97.71% | 61.73% | |
| Net Margin | -134.73% | -62.97% |
| 97.74% | 53.26% |
10 Analysts have issued a sales forecast SpringWorks Therapeutics Inc 2025 . The average SpringWorks Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an SpringWorks Therapeutics Inc EBITDA forecast 2025. The average SpringWorks Therapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 SpringWorks Therapeutics Inc Analysts have issued a net profit forecast 2025. The average SpringWorks Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -3.48 | -2.81 |
| 32.43% | 19.25% | |
| P/E | negative | |
| EV/Sales | 9.74 |
10 Analysts have issued a SpringWorks Therapeutics Inc forecast for earnings per share. The average SpringWorks Therapeutics Inc EPS is
This results in the following potential growth metrics and future valuations:
SpringWorks Therapeutics Inc...
Current SpringWorks Therapeutics Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Guggenheim |
Locked
➜
Locked
|
Locked | May 12 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Apr 29 2025 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Apr 29 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Apr 28 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 24 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Guggenheim:
Locked
➜
Locked
|
May 12 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 30 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Apr 29 2025 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Apr 29 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Apr 28 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 24 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 21 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
